Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 159,300 | 143,500 | 172,300 | 170,900 | 197,400 |
| Cost of Goods | 67,900 | 57,700 | 72,100 | 69,300 | 90,800 |
| Gross Profit | 91,400 | 85,800 | 100,200 | 101,600 | 106,600 |
| Operating Expenses | 98,400 | 82,500 | 87,500 | 91,800 | 98,800 |
| Operating Income | -6,100 | 4,000 | 12,800 | 10,100 | 8,600 |
| Interest Expense | 3,500 | 3,000 | 3,000 | 2,700 | 1,300 |
| Other Income | 500 | 700 | 300 | 200 | 0 |
| Pre-tax Income | -9,100 | 1,700 | 10,100 | 7,600 | 7,300 |
| Income Tax | -1,300 | 1,400 | -900 | 2,800 | 1,900 |
| Net Income Continuous | -7,800 | 300 | 11,000 | 4,800 | 5,400 |
| Net Income Discontinuous | 7,300 | 16,600 | 4,700 | 7,700 | N/A |
| Net Income | $-500 | $16,900 | $15,700 | $12,500 | $5,400 |
| EPS Basic Total Ops | -0.01 | 0.36 | 0.34 | 0.27 | 0.11 |
| EPS Basic Continuous Ops | -0.17 | 0.01 | 0.24 | 0.10 | 0.11 |
| EPS Basic Discontinuous Ops | 0.16 | 0.35 | 0.10 | 0.17 | N/A |
| EPS Diluted Total Ops | -0.01 | 0.37 | 0.33 | 0.26 | 0.11 |
| EPS Diluted Continuous Ops | -0.17 | 0.02 | 0.23 | 0.10 | 0.11 |
| EPS Diluted Discontinuous Ops | 0.16 | 0.35 | 0.10 | 0.16 | N/A |
| EBITDA(a) | $6,000 | $17,400 | $24,400 | $21,700 | $19,700 |